Research Article

Effects of a Flexibility and Relaxation Programme, Walking, and Nordic Walking on Parkinson's Disease

Table 2

Medication used by the patient groups.

MedicationRelaxation and flexibility group  
Walking group  
Nordic walking group  
Total number(%)Total number(%)Total number(%)

Levodopa20662273.32066.7
Dopamine agonists27902686.72686.7
Mao-Inhibitor12401343.31240
COMT-Inhibitor1136.712401033
Amantadine10331033930
-blockers413.3310310
ACE-inhibitors310310310
Antidepressants723.3826.7826.7

(%) = percentage.